Ticker: EYEG

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) is a clinical-stage pharmaceutical company currently focused on developing therapies for ophthalmic diseases. In its recent financial report for the quarter ending June 30, 2025, the company revealed significant developments, including collaborations and...